Wire Stories
-
456Radware H1 2022 Report: Malicious DDoS Attacks Climb 203%
Activity related to the Russian invasion of Ukraine causes shifts in the threat landscape Patriotic hacktivism drives surge in DDoS activity as...
-
460Radware H1 2022 Report: Malicious DDoS Attacks Climb 203%
Activity related to the Russian invasion of Ukraine causes shifts in the threat landscape Patriotic hacktivism drives surge in DDoS activity as...
-
483upGrad Appoints Myleeta AgaWilliams as CEO � International, in Push to Expand its Global Edtech Business
Myleeta assumes Office in August to accelerate the brand’s international footprint and support expansion plans SINGAPORE–(BUSINESS WIRE)–#CampusPrograms—upGrad, Asia�s largest higher EdTech Company,...
-
540upGrad Appoints Myleeta AgaWilliams as CEO � International, in Push to Expand its Global Edtech Business
Myleeta assumes Office in August to accelerate the brand’s international footprint and support expansion plans SINGAPORE–(BUSINESS WIRE)–#CampusPrograms—upGrad, Asia�s largest higher EdTech Company,...
-
450OneConnect Announces Second Quarter and Half Year 2022 Unaudited Financial Results
Revenue Up by 17.2% and Adjusted Net Profit Margin1 Improved by 17.3ppt YoY for Second Quarter 2022 SHENZHEN, China–(BUSINESS WIRE)–OneConnect Financial Technology...
-
639Inseego MiFi� X PRO 5G Now Available at Telstra in Australia
10th generation MiFi� brand mobile hotspot offers expanded 5G and enterprise-specific features SAN DIEGO & SYDNEY–(BUSINESS WIRE)–$INSG #5G—Inseego Corp. (Nasdaq: INSG), a...
-
474Sievi Capital Plc�s Half-Year Report 1 January�30 June 2022
Sievi Capital Plc Stock exchange release 17 August 2022 at 8:00 am EEST Sievi Capital Plc�s Half-Year Report 1 January�30 June 2022...
-
554
Technip Energies, Subsea 7 and Samkang M&T to Perform FEED for Gray Whale 3 Floating Offshore Wind Project in South Korea
PARIS–(BUSINESS WIRE)–Technip Energies (Paris:TE) (ISIN:NL0014559478), in consortium with Subsea 7 and Samkang M&T has been selected by Corio Generation and TotalEnergies to...
-
516Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics...
-
489EMQ Boosts International Payments Capabilities to Over 170 Markets with Launch of Global USD Offering
Enterprises, FIs, payments businesses and marketplaces can more efficiently disburse USD payments and benefit from rapid global expansion to drive growth HONG...
